Hecht Beth bought XERS
January 30, 2026 · Form 4 insider transaction
Hecht Beth bought 162,162 shares of Xeris Biopharma Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
162,162
Price
$0.00
Total value
N/A
InsiderHecht Beth
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 2, 2026
Shares owned after162,162
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date.